Cosmo Pharmaceuticals N.V.
SIX:COPN.SW
77.2 (CHF) • At close September 18, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Cosmo Pharmaceuticals N.V. |
Symbool | COPN.SW |
Munteenheid | CHF |
Prijs | 77.2 |
Beurswaarde | 1,238,740,701 |
Dividendpercentage | 1.41% |
52-weken bereik | 33.7 - 80.6 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Alessandro E. Della Cha LL.M |
Website | https://www.cosmopharma.com |
An error occurred while fetching data.
Over Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CHF)
Cijfers zijn in miljoenen (CHF)